logo

FATE

Fate Therapeutics·NASDAQ
--
--(--)
--
--(--)

FATE fundamentals

Fate Therapeutics (FATE) released its earnings on Aug 12, 2025: revenue was 1.91M (YoY -71.84%), beat estimates; EPS was -0.29 (YoY +12.12%), beat estimates.
Revenue / YoY
1.91M
-71.84%
EPS / YoY
-0.29
+12.12%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 12, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

FATE has released its 2025 Q4 earnings report, with revenue of 1.37M, reflecting a YoY change of -26.40%, and net profit of -32.37M, showing a YoY change of 37.92%. The Sankey diagram below clearly presents FATE's revenue sources and cost distribution.

Key Indicators

Fate Therapeutics (FATE) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Fate Therapeutics (FATE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Fate Therapeutics (FATE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Fate Therapeutics (FATE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Fate Therapeutics (FATE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Fate Therapeutics (FATE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield